NanoString Technologies, Inc. (NASDAQ:NSTG) is reporting third quarter earnings results on Monday 9th November 2020, after market close.
The consensus estimates from Thomson Reuters are loss of $ 0.6 per share.
For the full year, analysts predict revenues of $ 111.38 million, while looking forward to loss of $ 2.84 per share.
Previous Quarter Performance
NanoString Technologies, Inc. announced loss for the second quarter of $ 0.72 per share, from the revenue of $ 22.60 million. The quarterly revenues decreased 22.07 percent compared with the same quarter last year. The consensus estimates are loss of $ 0.52 per share from $ 16.16 million in revenue. The bottom line results missed street analysts by $ 0.2 or 38.46 percent, at the same time, top line results outshined analysts by $ 6.44 million or 39.85 percent.
Stock Performance
On Friday, shares of NanoString Technologies, Inc. has traded high as $ 40.92 and has cracked $ 38.76 on the downward trend, reaching $ 40.77 with volume of 705.80 thousand shares.
According to the previous trading day, closing price of $ 40.77, representing a 181.59 % increase from the 52 week low of $ 13.85 and a 16.9 % decrease over the 52 week high of $ 46.93.
The company has a market capital of $ 1.78 billion and is part of the Healthcare sector and Biotechnology industry.
Recent Analyst recommendations
- On 9th September 2020, initiated by Morgan Stanley at Equal-Weight rating, with $ 43.00 target price.
Conference Call
NanoString Technologies, Inc. will be hosting a conference call at 4:30 PM eastern time on 9th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.nanostring.com
NanoString Technologies, Inc. provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system.
